article thumbnail

The Bizarre Career of Damien Hirst

Plagiarism Today

In 2010, artist Charles Thomspon compiled a list of 15 separate plagiarism allegations against Hirst and published them in the art magazine Jackdaw. This market has been described repeatedly as a scam. Simply put, the art market is a small, highly concentrated market that values the cache of the artist over their originality.

article thumbnail

US Biosimilar Market Expands As BPCIA Turns 10

Bio Law Blog

biosimilar market. The BPCIA, signed into law on March 23, 2010, was slow to get going. biosimilar market has greatly expanded. Sixteen biosimilar products are now marketed in the U.S. Sixteen biosimilar products are now marketed in the U.S. Biosimilars on US Market. market with six. Biosimilar Maker.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Authenticating Prior Art

Patently-O

Valve submitted a printout of Burns and argues that it was a printed copy of an online review of a Scuf controller from 2010. In particular, one of the inventors (Burgess) testified that he had facilitated the publication back in 2010 for marketing purposes. ” Fed. See, e.g., MPEP § 2128 (9th ed. Vacated and remanded.

Art 124
article thumbnail

Manufacturing Opens More Doors to Women

U.S. Department of Commerce

manufacturing experienced a substantial decline in employment from 2000 to 2010 due largely to the 2008 Great Recession but rebounded – until the Covid-19 pandemic hit in 2020. Many now are high-tech , from design and marketing to administration, finance and sales, and cybersecurity. Thu, 10/06/2022 - 13:30. Manufacturing.

Marketing 111
article thumbnail

Proxy Advisors And Its Regulations

IP and Legal Filings

Because shareholders acquire shares on the stock market and have no personal access to the company, it is not possible to have every member present at every meeting. When the Satyam fraud occurred in 2009, the whole financial market trembled.

article thumbnail

UK takes uncompromising approach to interpretation of "the product" under Art. 3(a) SPC Regulation (Newron v Comptroller [2023] EWHC 1471)

The IPKat

The decision considered what it means for "the product" in Article 3(a) to be protected by a marketing authorisation (see also IPKat: The SPC alphabet ). The marketing authorisation in the case specifically recited the active ingredient "safinamide".

Art 117
article thumbnail

Now Available! Updated Goodwin’s Guide to Biosimilars Litigation and Regulation in the U.S., 2023-2024

LexBlog IP

As regular Big Molecule Watch readers know, the Biologics Price Competition and Innovation Act (“BPCIA”) was signed into law as part of the Affordable Care Act on March 23, 2010, creating an abbreviated licensure pathway for “biosimilar” and “interchangeable” biological products.